Clinical significance of serum total sialic acid in cholangiocarcinoma.

[1]  R. Carubelli,et al.  Sialic acid in human cancer , 1972, Experientia.

[2]  P. Bauer,et al.  Serum sialic acid in malignant tumors, bacterial infections, and chronic liver diseases , 2005, Journal of Cancer Research and Clinical Oncology.

[3]  C. Wongkham,et al.  Serum MUC5AC mucin as a potential marker for cholangiocarcinoma. , 2003, Cancer letters.

[4]  C. Wongkham,et al.  Serum total sialic acid in cholangiocarcinoma patients: an ROC curve analysis. , 2001, Clinical biochemistry.

[5]  J. Fujita,et al.  Role of Carbohydrate Antigens Sialyl Lewis (a) (CA19-9) in Bronchoalveolar Lavage in Patients with Pulmonary Fibrosis , 2000, Respiration.

[6]  D. Thornton,et al.  Physical characterization of the MUC5AC mucin: a highly oligomeric glycoprotein whether isolated from cell culture or in vivo from respiratory mucous secretions. , 2000, The Biochemical journal.

[7]  A. Gebert,et al.  Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180 , 2000, Inflammation Research.

[8]  J. H. Martinez‐Liarte,et al.  Serum sialic acid in malignant melanoma patients: an ROC curve analysis. , 1999, Anticancer research.

[9]  I. Jääskeläinen,et al.  Occurrence of sialic acids in healthy humans and different disorders , 1999, European journal of clinical investigation.

[10]  H. Baloglu,et al.  Tissue and serum sialidase levels in breast cancer. , 1999, Cancer letters.

[11]  M. Cybulski,et al.  Total serum sialic acid concentration as a supporting marker of malignancy in ovarian neoplasia. , 1999, European journal of gynaecological oncology.

[12]  Y. Kim,et al.  Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles. , 1998, American journal of clinical pathology.

[13]  A. Semczuk,et al.  Sialic acid concentration in serum and tissue of endometrial cancer patients. , 1998, European journal of obstetrics, gynecology, and reproductive biology.

[14]  S. Yonezawa,et al.  Expression of mucin antigens in human cancers and its relationship with malignancy potential , 1997, Pathology international.

[15]  I. Mononen,et al.  Total and lipid-bound serum sialic acid in benign and malignant breast disease. , 1997, Anticancer research.

[16]  M. Páez de la Cadena,et al.  Sialic acid levels in serum and tissue from colorectal cancer patients. , 1997, Cancer letters.

[17]  H. Baloglu,et al.  Tissue sialic acid and fibronectin levels in human prostatic cancer. , 1996, Cancer letters.

[18]  Y. Kim,et al.  Diversity of mucin genes, structure, function, and expression. , 1995, Gastroenterology.

[19]  R. Rawal,et al.  Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer. , 1995, Neoplasma.

[20]  Y. Nakanuma,et al.  Expression of Mucin core protein of mammary type in primary liver cancer , 1994, Hepatology.

[21]  S. Narayanan,et al.  Sialic acid as a tumor marker. , 1994, Annals of clinical and laboratory science.

[22]  S. Adhvaryu,et al.  Clinical application of serum levels of sialic acid, fucose and seromucoid fraction as tumour markers in human leukemias. , 1994, Anticancer research.

[23]  G. Gupta,et al.  Serum sialic acid--an important cancer marker. , 1993, Indian journal of cancer.

[24]  G. Gores,et al.  Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. , 1993, Mayo Clinic proceedings.

[25]  L. Råstam,et al.  Tumours of the central nervous system and serum sialic acid concentration in men and women. , 1993, British Journal of Cancer.

[26]  M. Crook.  The determination of plasma or serum sialic acid. , 1993, Clinical biochemistry.

[27]  I. Vivas,et al.  Total and lipid-bound serum sialic acid as markers for carcinoma of the uterine cervix. , 1992, Gynecologic oncology.

[28]  J J Visser,et al.  The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature. , 1992, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[29]  M. W. Riley,et al.  Serum sialic acid and carcinoembryonic levels in the detection and monitoring of colorectal cancer , 1990, Diseases of the colon and rectum.

[30]  F. Minni,et al.  Increased CMP‐NeuAc:Galβ1,4GlcNAc‐R α2,6 sialyltransferase activity in human colorectal cancer tissues , 1989 .

[31]  Zhong-shu Yan,et al.  The application of leukocyte adherence inhibition assay to patients with colorectal cancer , 1989, Diseases of the colon and rectum.

[32]  W. Rokicki,et al.  [Usefulness of determining the levels of sialic acid in the blood serum, pulmonary homogenates and urine of patients with lung cancer]. , 1987, Nowotwory.

[33]  P. Maity.  Sialic acid in cervical carcinoma patients. , 1987, European journal of gynaecological oncology.

[34]  James D. Jones,et al.  Significance of serum protein and lipid‐bound sialic acid as a marker for genitourinary malignancies , 1986, Cancer.

[35]  G. Turner,et al.  Relation between raised concentrations of fucose, sialic acid, and acute phase proteins in serum from patients with cancer: choosing suitable serum glycoprotein markers. , 1985, Journal of clinical pathology.

[36]  J. Griffiths,et al.  Plasma sialyl transferase total and isoenzyme activity in the diagnosis of cancer of the colon. , 1982, Clinical biochemistry.

[37]  E. Deutsch,et al.  Serum sialyltransferase levels as a parameter in the diagnosis and follow-up of gastrointestinal tumors. , 1980, Cancer research.

[38]  Y. S. Kim,et al.  Alterations of membrane glycopeptides in human colonic adenocarcinoma. , 1974, Proceedings of the National Academy of Sciences of the United States of America.